Published: 06/14/2022 02:03 GMT Lilly(Eli) & Co (LLY) - :fda Approves Lilly and Incyte's Olumiant® (baricitinib) As First and Only Systemic Medicine for Adults With Severe Alopecia Areata.
Lilly Also Expects Regulatory Decisions for Olumiant in Aa in European Union and Japan in 2022.
